Mirion Technologies Joins Influential Nuclear Energy Organizations to Further Bolster Nuclear Initiatives
Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, has announced its membership in two major nuclear industry organizations. The company has joined the Nuclear Energy Institute (NEI) and enhanced its partnership with the American Nuclear Society (ANS) as a Trustees of Nuclear partner.
Through NEI membership, Mirion will participate in policy discussions shaping the nuclear industry and advocate for nuclear energy growth policies. As an ANS Trustee of Nuclear, the company will serve on its leadership council. CEO Thomas Logan emphasized Mirion's unique position across the nuclear landscape and its commitment to advancing the industry through these strategic partnerships.
Mirion Technologies (NYSE: MIR), un fornitore leader di soluzioni avanzate per la sicurezza dalle radiazioni, ha annunciato la sua adesione a due importanti organizzazioni del settore nucleare. L'azienda è entrata a far parte del Nuclear Energy Institute (NEI) e ha rafforzato la sua partnership con l'American Nuclear Society (ANS) come partner Trustee of Nuclear.
Attraverso l'adesione al NEI, Mirion parteciperà a discussioni politiche che plasmano l'industria nucleare e sosterrà politiche per la crescita dell'energia nucleare. In qualità di Trustee of Nuclear dell'ANS, l'azienda farà parte del suo consiglio di leadership. Il CEO Thomas Logan ha sottolineato la posizione unica di Mirion nel panorama nucleare e il suo impegno a far progredire l'industria attraverso queste partnership strategiche.
Mirion Technologies (NYSE: MIR), un proveedor líder de soluciones avanzadas de seguridad radiológica, ha anunciado su membresía en dos importantes organizaciones de la industria nuclear. La empresa se ha unido al Nuclear Energy Institute (NEI) y ha fortalecido su asociación con la American Nuclear Society (ANS) como socio Trustee of Nuclear.
A través de la membresía en el NEI, Mirion participará en discusiones políticas que están dando forma a la industria nuclear y abogará por políticas de crecimiento de la energía nuclear. Como Trustee of Nuclear de la ANS, la empresa formará parte de su consejo de liderazgo. El CEO Thomas Logan enfatizó la posición única de Mirion en el panorama nuclear y su compromiso de avanzar en la industria a través de estas asociaciones estratégicas.
미리온 테크놀로지스 (NYSE: MIR), 첨단 방사선 안전 솔루션의 선도적인 제공업체가 두 개의 주요 원자력 산업 조직에 가입했다고 발표했습니다. 이 회사는 원자력 에너지 연구소 (NEI)에 가입하고 미국 원자력 학회 (ANS)와의 파트너십을 Trustee of Nuclear 파트너로 강화했습니다.
NEI 회원으로서 미리온은 원자력 산업을 형성하는 정책 논의에 참여하고 원자력 에너지 성장 정책을 옹호할 것입니다. ANS의 Trustee of Nuclear로서 이 회사는 리더십 위원회에서 활동할 것입니다. CEO 토마스 로건은 원자력 분야에서 미리온의 독특한 위치와 이러한 전략적 파트너십을 통해 산업을 발전시키겠다는 의지를 강조했습니다.
Mirion Technologies (NYSE: MIR), un fournisseur leader de solutions avancées de sécurité radiologique, a annoncé son adhésion à deux grandes organisations de l'industrie nucléaire. L'entreprise a rejoint le Nuclear Energy Institute (NEI) et a renforcé son partenariat avec l'American Nuclear Society (ANS) en tant que partenaire Trustee of Nuclear.
Grâce à l'adhésion au NEI, Mirion participera aux discussions politiques façonnant l'industrie nucléaire et plaidera en faveur de politiques de croissance de l'énergie nucléaire. En tant que Trustee of Nuclear de l'ANS, l'entreprise siégera à son conseil de direction. Le PDG Thomas Logan a souligné la position unique de Mirion dans le paysage nucléaire et son engagement à faire progresser l'industrie grâce à ces partenariats stratégiques.
Mirion Technologies (NYSE: MIR), ein führender Anbieter von fortschrittlichen Lösungen für Strahlensicherheit, hat seine Mitgliedschaft in zwei wichtigen Organisationen der Nuklearindustrie bekannt gegeben. Das Unternehmen ist dem Nuclear Energy Institute (NEI) beigetreten und hat seine Partnerschaft mit der American Nuclear Society (ANS) als Trustee of Nuclear-Partner verstärkt.
Durch die Mitgliedschaft im NEI wird Mirion an politischen Diskussionen teilnehmen, die die Nuklearindustrie gestalten, und sich für Wachstumsrichtlinien für die Kernenergie einsetzen. Als Trustee of Nuclear der ANS wird das Unternehmen im Führungsgremium tätig sein. CEO Thomas Logan betonte die einzigartige Position von Mirion im Nuklearbereich und das Engagement des Unternehmens, die Branche durch diese strategischen Partnerschaften voranzubringen.
- Strategic positioning through membership in key nuclear industry organizations
- Enhanced influence in nuclear policy-making through NEI membership
- Elevated industry leadership role through ANS Trustees of Nuclear position
- None.
Mirion joins the Nuclear Energy Institute, enhances membership with the American Nuclear Society as a Trustees of Nuclear partner.
NEI is the policy organization of the nuclear energy industry in
ANS is the premier international professional organization of engineers, scientists, technologists, teachers, and healthcare providers devoted to the peaceful applications of nuclear science and technology. As part of its enhanced membership in ANS, Mirion will become an ANS Trustee of Nuclear and serve on its leadership council.
"As one of the only companies uniquely present across the full span of the nuclear landscape, we have an important role to play in the Nuclear Renaissance. We are thrilled to build upon our bonds with the Nuclear Energy Institute and the American Nuclear Society,” said Mirion CEO Thomas Logan. “These memberships underscore our commitment to advancing the nuclear industry and continued collaboration with leading experts and organizations. We look forward to contributing to the innovative solutions and best practices that will shape the future of nuclear energy."
About Mirion
Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. Focused on nuclear and safety, the Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. Dedicated to driving better patient outcomes, the Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance the delivery and ensure safety across the medical landscape. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250313690877/en/
For investor inquiries:
Eric Linn
ir@mirion.com
For media inquiries:
Erin Schesny
media@mirion.com
Source: Mirion